Exact Sciences (EXAS) | Stock Overview & Key Data
Exact Sciences Performance Comparison
Stock Range
Today's Range
Low: $46.57
High: $47.86
on August 22, 2025
52 Week Range
Low: $38.81
High: $72.83
on November 5, 2024
All-Time High: $159.54 on January 25, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$8.5B
EPS
-5.45
P/E Ratio (TTM)
-8.17
Forward P/E
-132.62
P/B Ratio
3.46
PEG Ratio
0.09
Div. Yield
N/A
ROE
-35.51%
Beta
0.928
Debt to Equity
102.73
Financial Highlights
Profitability
Gross Margin
69.35%
Operating Margin
0.34%
Profit Margin
-34.19%
Returns and Earnings
Return on Assets (TTM)
-1.39%
Return on Equity (TTM)
-35.51%
EBITDA
$30.3M
Net Income (TTM)
$-1.0B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$15.84
Quarterly Revenue Growth (YoY)
16.00%
Quarterly Earnings Growth (YoY)
15.99%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Exact Sciences EXAS | 8.54B Mid-cap | 3.76% | -3.47% | -17.95% | -5.24% | -18.00% | -21.81% | 26.47% | -36.19% |
| Thermo Fisher TMO | 184.10B Large-cap | -0.26% | 19.46% | 21.46% | -9.16% | -7.43% | -20.19% | -14.18% | 13.97% |
| Danaher DHR | 151.04B Large-cap | -3.01% | 8.42% | 9.15% | -3.01% | -11.27% | -24.34% | -17.95% | 11.85% |
| Charles River CRL | 7.71B Mid-cap | -0.81% | 3.17% | 14.49% | -5.20% | -15.39% | -24.71% | -24.54% | -28.93% |
| Guardant Health GH | 7.34B Mid-cap | 1.52% | 34.27% | 65.22% | 42.94% | 92.89% | 111.16% | 21.90% | -36.26% |
| RadNet RDNT | 5.22B Mid-cap | -0.20% | 18.42% | 18.17% | 15.37% | -2.20% | 5.55% | 226.71% | 358.93% |
Ownership & Short Interest
Insider Ownership
0.91%
Institutional Ownership
95.58%
Shares Short
7M
Short Ratio
3.00
Short % of Shares Outstanding
4.15%
Average 10-Day Volume
5M
Average 90-Day Volume
3M
Exact Sciences Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Exact Sciences would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is EXAS's 52-week high and low?
- In the last 52 weeks, Exact Sciences reached a high of $72.83 (on November 5, 2024) and a low of $38.81 (on N/A).
- What is the market cap and P/E ratio for EXAS?
- Curious about Exact Sciences's size and valuation? Its market capitalization stands at 8.54B. When it comes to valuation, the P/E ratio (trailing twelve months) is -8.17, and the forward P/E (looking ahead) is -132.62.
- Does EXAS pay dividends? If so, what's the yield?
- As for dividends, Exact Sciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Exact Sciences's main competitors or similar companies to consider before investing?
When looking at Exact Sciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO184.10B Healthcare Diagnostics & Research -20.19% -14.18% Danaher
DHR151.04B Healthcare Diagnostics & Research -24.34% -17.95% Charles River
CRL7.71B Healthcare Diagnostics & Research -24.71% -24.54% Guardant Health
GH7.34B Healthcare Diagnostics & Research 111.16% 21.90% RadNet
RDNT5.22B Healthcare Diagnostics & Research 5.55% 226.71% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Exact Sciences Corp? (e.g., ROE, Debt/Equity)
- To get a sense of Exact Sciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -35.51%, the Debt to Equity ratio from the most recent quarter is 102.73, and its Gross Profit Margin stands at 69.35%.
- What is the recent revenue and earnings growth for EXAS?
- Looking at Exact Sciences's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.00%, and quarterly earnings saw a YoY growth of 15.99%.
- How much of EXAS stock is held by insiders and institutions?
- Wondering who owns Exact Sciences stock? Company insiders (like executives and directors) hold about 0.91% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 95.58%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.